Investigating the Effect of Iron Chelation Therapy With Deferasirox on Liver Aminotransferases Levels in Transfusion-dependent β-thalassemia Patients
Background Various body tissues of β-thalassemia patients are exposed to the destructive effects of iron overload due to chronic blood transfusions. Therefore, the decision to start regular blood transfusion therapy for these patients often leads to the administration of iron chelators. Deferasirox...
Saved in:
| Main Authors: | Shayan Pourkazem, Mohammadreza Sharifi Rad, Adel Baghersalimi, Soodeh Salehi, Mercedeh Enshaei, Vahid Aminzadeh, Behrang Motamed, Bahram Darbandi |
|---|---|
| Format: | Article |
| Language: | fas |
| Published: |
Guilan University of Medical Sciences
2024-06-01
|
| Series: | مجله دانشگاه علوم پزشکی گیلان |
| Subjects: | |
| Online Access: | http://journal.gums.ac.ir/article-1-2621-en.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Deferasirox in Indian children with thalassemia major: 3 years experience
by: Mayank Dhamija, et al.
Published: (2013-01-01) -
THE RELATION BETWEEN TYPES OF IRON CHELATORS AND FERITIN ON OSTEOCALCIN OF THALASSEMIA PATIENTS WITH REPEATED TRANSFUSIONS
by: Sesa Amelia, et al.
Published: (2020-01-01) -
THE ANTIOXIDANT EFFECTS OF CAPPARIS OVATA AND DEFERASIROX IN PATIENTS WITH THALASSEMIA MAJOR
by: Handan Duman, et al.
Published: (2014-08-01) -
DEFERASIROX: OVER A DECADE OF EXPERIENCE IN THALASSEMIA
by: Ali Taher
Published: (2018-11-01) -
IRON CHELATION THERAPY IN THALASSEMIA SYNDROMES
by: Paolo Cianciulli
Published: (2009-06-01)